Paul D Boutin, MD | |
51 Fairview Street, Brattleboro, VT 05301-6629 | |
(802) 254-6028 | |
(802) 254-7501 |
Full Name | Paul D Boutin |
---|---|
Gender | Male |
Speciality | Psychiatry |
Experience | 22 Years |
Location | 51 Fairview Street, Brattleboro, Vermont |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689787673 | NPI | - | NPPES |
1013948 | Medicaid | VT | |
3113771 | Medicaid | NH |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Health Care And Rehabilitation Services Of Southeastern Vermont Inc | 4183698830 | 15 |
News Archive
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of a new range of assay kits utilizing AlphaLISA technology to help improve the safety testing, manufacturing and quality control of biotherapeutic drugs.
KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today a successful Type B meeting with the Food and Drug Administration (FDA) for its lead pain candidate, KP201.
Neuroblastoma is among the most common of childhood cancers and fortunately, some children will get better spontaneously. Yet for children with high-risk disease the outlook is poor: more than half will relapse despite chemotherapy.
Why do some people who are exposed to tuberculosis not become infected or develop the disease? Dr. Erwin Schurr and his team at the Research Institute from the McGill University Health Centre (RI-MUHC), in collaboration with Dr. Alexandre Alcais, from the Institut national de la sant- et de la recherche m-dicale (INSERM) in Paris, has shed light on this question for the first time. Their
› Verified 5 days ago
Entity Name | Health Care And Rehabilitation Services Of Southeastern Vermont Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790861342 PECOS PAC ID: 4183698830 Enrollment ID: O20040819001433 |
News Archive
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of a new range of assay kits utilizing AlphaLISA technology to help improve the safety testing, manufacturing and quality control of biotherapeutic drugs.
KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today a successful Type B meeting with the Food and Drug Administration (FDA) for its lead pain candidate, KP201.
Neuroblastoma is among the most common of childhood cancers and fortunately, some children will get better spontaneously. Yet for children with high-risk disease the outlook is poor: more than half will relapse despite chemotherapy.
Why do some people who are exposed to tuberculosis not become infected or develop the disease? Dr. Erwin Schurr and his team at the Research Institute from the McGill University Health Centre (RI-MUHC), in collaboration with Dr. Alexandre Alcais, from the Institut national de la sant- et de la recherche m-dicale (INSERM) in Paris, has shed light on this question for the first time. Their
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Paul D Boutin, MD 390 River Street, Springfield, VT 05156-2226 Ph: (802) 886-4500 | Paul D Boutin, MD 51 Fairview Street, Brattleboro, VT 05301-6629 Ph: (802) 254-6028 |
News Archive
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of a new range of assay kits utilizing AlphaLISA technology to help improve the safety testing, manufacturing and quality control of biotherapeutic drugs.
KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today a successful Type B meeting with the Food and Drug Administration (FDA) for its lead pain candidate, KP201.
Neuroblastoma is among the most common of childhood cancers and fortunately, some children will get better spontaneously. Yet for children with high-risk disease the outlook is poor: more than half will relapse despite chemotherapy.
Why do some people who are exposed to tuberculosis not become infected or develop the disease? Dr. Erwin Schurr and his team at the Research Institute from the McGill University Health Centre (RI-MUHC), in collaboration with Dr. Alexandre Alcais, from the Institut national de la sant- et de la recherche m-dicale (INSERM) in Paris, has shed light on this question for the first time. Their
› Verified 5 days ago
Dr. Saba Salam, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 830 Western Ave, Brattleboro, VT 05301 Phone: 802-246-0781 Fax: 802-246-0742 | |
Timothy Larosa, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Anna Marsh Lane, Brattleboro, VT 05302 Phone: 802-258-3707 Fax: 802-258-3788 | |
Dorothea L. De Gutis, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 51 Fairview St, Brattleboro, VT 05301 Phone: 802-254-6028 Fax: 802-254-7501 | |
Dr. Lance Budge Thigpen, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Anna Marsh Lane, Brattleboro, VT 05302 Phone: 802-258-7785 Fax: 802-258-3723 | |
Dr. Milangel Thaymee Concepcion Zayas, MD, MPH Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Anna Marsh Lane, Brattleboro Retreat- Anna Marsh Behavioral Care Clinic, Brattleboro, VT 05302 Phone: 802-257-7785 | |
Elizabeth H Joseph, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: Anna Marsh Lane, Brattleboro Retreat, Brattleboro, VT 05302 Phone: 802-258-4354 | |
Stuart A. Copans, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 51 Fairview St., Hcrs, Brattleboro, VT 05301 Phone: 802-254-6028 |